AlphaTON Capital Corp Files 6-K Report

Ticker: ATON · Form: 6-K · Filed: Sep 25, 2025 · CIK: 1095435

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

TL;DR

AlphaTON Capital Corp (fka Portage Biotech) filed a 6-K, standard foreign private issuer report.

AI Summary

AlphaTON Capital Corp, formerly Portage Biotech Inc., filed a Form 6-K on September 25, 2025. The company, which operates in the Pharmaceutical Preparations sector, is headquartered in Tortola, British Virgin Islands. This filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates ongoing reporting obligations for AlphaTON Capital Corp as a foreign private issuer, providing transparency to investors about its regulatory compliance.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain specific financial or operational news that would typically increase risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a Form 6-K filing?

A Form 6-K is a report of a foreign private issuer required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded.

When was AlphaTON Capital Corp previously known by another name?

AlphaTON Capital Corp was formerly known as Portage Biotech Inc., with a name change date of August 22, 2013.

What is AlphaTON Capital Corp's industry classification?

AlphaTON Capital Corp is classified under Pharmaceutical Preparations [2834].

Where is AlphaTON Capital Corp's principal executive office located?

The principal executive office of AlphaTON Capital Corp is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands.

Does AlphaTON Capital Corp file annual reports under Form 20-F or 40-F?

AlphaTON Capital Corp indicates it files annual reports under cover of Form 20-F.

Filing Stats: 270 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-09-25 15:00:43

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025 Commission File Number: 001-40086 AlphaTON Capital Corp (Translation of registrant's name into English) Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ] Form 40-F [ ] INCORPORATION BY REFERENCE This report on Form 6-K (including any exhibits attached hereto) shall be deemed to be incorporated by reference into the registration statements on Form S-8 (File No. 333-275842 and 333-289199) and Form F-3, as amended (File No. 333-286961) of AlphaTON Capital Corp (including any prospectuses forming a part of each such registration statement) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. On September 25, 2025, AlphaTON Capital Corp (the “Company”) issued a press release announcing the closing of the private placement. A copy of the press release is attached hereto as Exhibit 99.1. EXHIBITS Exhibit No. Description 99.1 Press Release, dated September 25, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 25, 2025 ALPHATON CAPITAL CORP By: /s/ Andrea Park Andrea Park Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing